Open AccessValidity and reliability of a point‐of‐care nerve conduction device in diabetes patients
Author(s) -
Shibata Yuka,
Himeno Tatsuhito,
Kamiya Taeko,
Tani Hiroya,
Nakayama Takayuki,
Kojima Chika,
SugiuraRoth Yukako,
Naito Ena,
Kondo Masaki,
Tsunekawa Shin,
Kato Yoshiro,
Nakamura Jiro,
Kamiya Hideki
Publication year - 2019
Publication title -
journal of diabetes investigation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.089
H-Index - 50
eISSN - 2040-1124
pISSN - 2040-1116
DOI - 10.1111/jdi.13007
Subject(s) - medicine , intraclass correlation , electromyography , sural nerve , reproducibility , polyneuropathy , diabetes mellitus , nerve conduction velocity , nerve conduction study , inter rater reliability , gold standard (test) , diabetic neuropathy , intra rater reliability , reliability (semiconductor) , physical medicine and rehabilitation , biomedical engineering , surgery , nerve conduction , statistics , rating scale , mathematics , endocrinology , clinical psychology , confidence interval , power (physics) , physics , quantum mechanics , psychometrics
Aims/Introduction Although nerve conduction study (NCS) using a standard electromyography system (EMGS) is considered to be the gold standard in evaluating diabetic polyneuropathy, this examination requires expensive equipment and well‐trained technicians. We aimed to validate a point‐of‐care device, NC‐stat/DPNCheck™, that has been developed for widespread use of NCS in diabetic polyneuropathy. Materials and Methods Diabetes patients underwent two kinds of NCS: DPNCheck™ and electromyography system. Inter‐/intrarater reliability of DPNCheck™ were also determined by the intraclass correlation coefficient. Results A total of 57 patients were evaluated. The parameters of NCS between the two methods correlated well ( r = 0.7734 for the sural nerve conduction velocity, r = 0.6155 for the amplitude of sural nerve action potential). The intraclass correlation coefficients were excellent (intrarater: the velocity 0.767, the amplitude 0.811; interrater: the velocity 0.974, the amplitude 0.834). Conclusions The point‐of‐care device has excellent reproducibility and good agreement with standard electromyography system. The device might be useful to evaluate diabetic polyneuropathy.